This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Genentech, Inc.. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: The Innovations of Theodore A. Omachi
Introduction
Theodore A. Omachi is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of medicine, particularly in the treatment of atopic dermatitis. His innovative work has led to the development of methods that utilize IL-13 antagonists for therapeutic purposes.
Latest Patents
Omachi holds a patent titled "Uses of IL-13 antagonists for treating atopic dermatitis." This patent outlines the applications of IL-13 antagonists in treating atopic dermatitis, as well as methods for reducing the severity of this condition through administration of these antagonists. His work in this area has the potential to improve the quality of life for many individuals suffering from this skin condition.
Career Highlights
Throughout his career, Theodore A. Omachi has worked with prominent companies in the pharmaceutical industry, including Genentech, Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to collaborate with leading experts and contribute to groundbreaking research.
Collaborations
Omachi has had the opportunity to work alongside talented individuals such as ChinYu Lin and Ryan Patrick Owen. These collaborations have enriched his research and have played a crucial role in the development of his innovative solutions.
Conclusion
Theodore A. Omachi's contributions to the field of medicine, particularly through his patent on IL-13 antagonists, highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of atopic dermatitis.